![]() ![]() The molecular mechanisms governing oncogenic Ras-driven cancers are complex and involve interacting signalling pathways. Activating mutations of the Ras gene are highly prevalent in human cancers and give rise to some of the most aggressive tumours. This explains both, the puzzling requirement of Egfr in oncogenic Ras-mediated overgrowth and the cooperation between Egfr and Hedgehog. These findings highlight a non-canonical Egfr signalling mechanism, centered on Arf6 as a novel regulator of Hh signalling. Blocking any step of this signalling cascade inhibits Hh signalling and correspondingly suppresses the growth of both, fly and human cancer cells harbouring oncogenic Ras mutations. Egfr then signals through Arf6, which regulates Hh transport to promote Hh signalling. Oncogenic Ras induces the expression of Egfr ligands. Using a Drosophila tumour model, we show that Egfr cooperates with oncogenic Ras via Arf6, which functions as a novel regulator of Hh signalling. How oncogenic Ras elicits and integrates Egfr and Hedgehog signals to drive overgrowth remains unclear. ![]() In turn, Egfr cooperates with Hedgehog signalling. Oncogenic Ras cooperates with Egfr, which cannot be explained by the canonical signalling paradigm. Multiple signalling events interact in cancer cells.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |